Cost-Per-Responder Analysis of Bimekizumab (IL-17A/F inhibitor) against IL-17A and IL-12/23 Targeted Therapies for Psoriatic Arthritis in Spain, based on Matching-Adjusted Indirect Comparisons (MAIC)
Cost-per-Responder Analysis of Bimekizumab (IL-17A/F Inhibitor) Against IL-23 Targeted Therapies for Psoriatic Arthritis in Spain, Based on Matching-Adjusted Indirect Comparisons (MAIC)
Recommendations for effective patient involvement in the assessment of medical devices
Comparative Narrative Review of Oncology Value Assessment Frameworks: Enfortumab Vedotin (EV) for Treatment of Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC)
Carga económica de la anemia asociada a la Enfermedad Renal Crónica en España
Budget impact analysis of a transanal irrigation for the treatment of low anterior resection syndrome in Spain
Población objetivo de la irrigación transanal en España
The clinical and economic value of a sustained response in the treatment of moderate-to-severe psoriasis in Spain: The Psovalue project
Budget Impact Analysis of a Solution for Sealant in Spain
La carga económica de la enfermedad meningocócica invasiva causada por Neisseria meningitidis del serogrupo B en España
